COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,886 Articles (22,568 medRxiv, 8,318 bioRxiv)

Most recent first Previous |  Page 1517: Articles 15161-15170  | Next

SARS-CoV-2 infection and reinfection in a seroepidemiological workplace cohort in the United States
Finch, E., Lowe, R., Fischinger, S., de St Aubin, M., Siddiqui, S. M., Dayal, D., Loesche, M. A., Rhee, J., Berger, S., Hu, Y., Gluck, M. J., Mormann, B., Hasdianda, M. A., Musk, E. R., Alter, G., Menon, A. S., Nilles, E. J., Kucharski, A. J.
10.1101/2021.05.04.21256609 — Posted: 2021-05-06
Derivation and external validation of a simple risk score to predict in-hospital mortality in patients hospitalized for COVID-19
Mann, C. Z., Abshire, C., Yost, M., Kaatz, S., Swaminathan, L., Flanders, S. A., Prescott, H. C., Gagnon-Bartsch, J. A.
10.1101/2021.05.04.21256599 — Posted: 2021-05-06
Obstructive sleep apnea is highly prevalent in COVID19 moderate to severe ARDS survivors: Findings of level I Polysomnography in a tertiary care hospital
Goyal, A., Saxena, K., Kar, A., Khurana, A., Pakhare, A. P., Bhagtana, P. K., Sridevi, C. S. K. R.
10.1101/2021.05.04.21256593 — Posted: 2021-05-06
Covid-19 and the South Asian Countries: factors ruling the pandemic
Biswas, T., Mondal, M., Bhattacharya, S., Sarkar, M., Dhara, B., Mitra, A. K., Chandra, A.
10.1101/2021.05.04.21256590 — Posted: 2021-05-06
Longitudinal SARS-CoV-2 infection study at Ulm University
Schoen, M., Lindenau, C., Boeckers, A., Altrock, C.-M., Krys, L., Nosanova, A., Lang, N., Reny, A., Kroschel, J., Pensel, E., Grab, C., Mayer, B., Messerer, D. A. C., Fassnacht, U., Delling, J. P., Horneffer, A., Zernickel, M., Debatin, K.-M., Muench, J., Kirchhoff, F., Wirth, T., Boeckers, T. M.
10.1101/2021.05.04.21256382 — Posted: 2021-05-06
Preliminary Analysis of Safety and Immunogenicity of a SARS-CoV-2 Variant Vaccine Booster
Wu, K., Choi, A., Koch, M., Ma, L., Hill, A., Nunna, N., Huang, W., Oestreicher, J., Colpitts, T., Bennett, H., Legault, H., Paila, Y., Nestorova, B., Ding, B., Pajon, R., Miller, J., Leav, B., Carfi, A., McPhee, R., Edwards, D.
10.1101/2021.05.05.21256716 — Posted: 2021-05-06 Discussion: Onsite
SARS-CoV-2 infections and hospitalizations among immigrants in Norway: significance of occupation, household crowding, education, household income and medical risk. A nationwide register study
Labberton, A. S., Godoy, A. A., Elgersma, I. H., Strand, B. H., Telle, K., Arnesen, T. M., Nygard, K. M., Indseth, T.
10.1101/2021.05.04.21256575 — Posted: 2021-05-06
Describing the burden of the COVID-19 pandemic in people with psoriasis: findings from a global cross-sectional study
Mahil, S. K., Yates, M., Yiu, Z. Z., Langan, S. M., Tsakok, T., Dand, N., Mason, K. J., McAteer, H., Meynall, F., Coker, B., Vincent, A., Urmston, D., Vesty, A., Kelly, J., Lancelot, C., Moorhead, L., Bachelez, H., Capon, F., Contreras, C. R., De La Cruz, C., Di Meglio, P., Gisondi, P., Jullien, D., Lambert, J., Naldi, L., Norton, S., Puig, L., Spuls, P., Torres, T., Warren, R. B., Waweru, H., Weinman, J., Brown, M. A., Galloway, J. B., Griffiths, C. M., Barker, J. N., Smith, C. H.
10.1101/2021.05.04.21256507 — Posted: 2021-05-06
Estimating vaccine efficacy against transmission via effect on viral load
Kennedy-Shaffer, L., Kahn, R., Lipsitch, M.
10.1101/2021.05.03.21256556 — Posted: 2021-05-06 Discussion: Onsite
The BNT162b2 mRNA vaccine against SARS-CoV-2 reprograms both adaptive and innate immune responses
Fohse, F. K., Geckin, B., Overheul, G. J., van de Maat, J., Kilic, G., Bulut, O., Dijkstra, H., Lemmers, H., Sarlea, S. A., Reijnders, M., Hoogerwerf, J., ten Oever, J., Simonetti, E., van de Veerdonk, F. L., Joosten, L. A. B., Haagmans, B. L., van Crevel, R., Li, Y., van Rij, R. P., GeurtsvanKessel, C., de Jonge, M. I., Dominguez-Andres, J., Netea, M. G.
10.1101/2021.05.03.21256520 — Posted: 2021-05-06 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).